TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.

Brian M Slomovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.